TFBS received the official approval letter from US FDA for the pre-approval inspection (PAI)

The US FDA completed a pre-approval inspection (PAI) of TFBS Bioscience’ brand new GMP testing facility on April 22, 2022. No 483 observation is cited. The positive outcome adds further assurance for our newly-established GMP testing business.